As a member benefit, LifeSciences BC publishes all our member news releases as we receive them. If you are a member and would like to have your news release published in BioLinks, send them along to Susan Ogilvie at [email protected] . Please include you company logo and a point of contact in the release.

Our BioLInks data shows us that we have an open rate of 39% with our member news getting the highest click - open rate. With a subscriber circulation of 4000+ readers, the data tells us the member news is a valuable read for our subscribers! So please, keep us up to date with your news - we all enjoy hearing about it!

The week has "zoomed" by and we have been busy attending virtual conferences that are connecting us to exciting global audiences and opportunities. Last week we attended Life Science Innovation Northwest presented by Life Science Washington, a two-day virtual event which brought together the life science community to discuss and feature some of the most compelling technology breakthroughs in the region.

 

We attended many great sessions and met with companies such as Imec , a world-leading R&D and innovation hub in nanoelectronics and digital technologies and Emergent BioSolutions, a multinational specialty biopharmaceutical company that focuses on emerging public health threats. During the networking component, we were able to profile the innovative BC Life Sciences sector and LSBC members.

 

The companies we met with had reached out specifically to make connections in British Columbia and discover ways in which they could partner with our members. It was wonderful to connect with international companies who expressed an interest in our life science sector. We are clearly on the international radar, as we have experienced many follow-up meetings with foreign governments, academic institutions and companies, from events like BIO. COVID has not slowed down our outreach and connectivity, some say it has emboldened it.

 

Next week’s BioLinks will be the last one for this summer but we will continue to post news announcements on our website and broadcast on social media, so please continue to share your news with us. We will return to our regular BioLinks schedule on Thursday, September 3 ^rd .

  Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET

SAN DIEGO, July 17, 2020 /PRNewswire/ —  DelMar Pharmaceuticals, Inc.  (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss the Company’s previously announced proposed acquisition of Adgero BioPharmaceuticals Holdings, Inc. READ MORE

VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announced that the U.S. Food and Drug Administration (FDA) has accepted ... READ MORE

VANCOUVER, British Columbia – July 21, 2020 – Aspect Biosystems, a biotechnology platform company pioneering the microfluidic 3D bioprinting of human tissues, is pleased to announce the appointment of Eric Roos as its new Chief Business Development Officer.  READ MORE

VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has commenced a registered underwritten public offering of its common shares (the “Offering”). READ MORE

VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the pricing of its underwritten public offering of 13,333,334 common shares (the “Offering”).   READ MORE

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2020) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or the "Company") and its subsidiary, iCo Therapeutics Australia Pty Ltd., announced today that the American Association of Pharmaceutical Scientists ("AAPS") has accepted two presentations regarding iCo's Oral Amphotericin B technology (iCo-019) for the AAPS 2020 PharmSci 360 Meeting to be held October 26-November 5, 2020 (the "PharmSci 360 Meeting"). READ MORE

The BC COVID-19 Strategic Research Advisory Committee (SRAC) published BC’s COVID-19 Strategic Research Framework Issue 1 on April 30, 2020. SRAC is currently working on Issue 2, and seeking input. Participation is available via online form  or email below.

 

1) Enabling Rapid Research Response

There are a variety of structures in place to facilitate research including expedited ethics processes and rapid data access.

 

2) Research Priorities

Work is under way to better understand the impact of COVID-19 and its control measures.

3) Knowledge Translation

What additional processes/approaches should be introduced to facilitate the production and use of research findings by decision-makers? By the public?

 

4) Additional Feedback

Are there any other considerations you would like to see included in the strategic research framework?

 

Please provide your responses by email: [email protected] or through the online form  by July 27, 2020.

One of Canada’s most successful biotechnology venture capital groups has drawn rare domestic institutional backing from outside Quebec and recruited one of the country’s pioneering investors in the space, further signs of the thriving sector’s resurgence. READ MORE

Gerri Sinclair has been appointed as B.C.’s new innovation commissioner, effective July 17, 2020. Sinclair will serve as advocate for the province’s tech sector. READ MORE

TORONTO--( BUSINESS WIRE )--The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the launch of the first eight Early Adopter Health Network (EAHN™) innovation projects .  READ MORE

MONTREAL -- The Business Development Bank of Canada is pledging $160 million for companies that are rich in intellectual property, but often struggle to access capital. READ MORE

The Student Work Placement Program is now accepting applications for healthcare placements. Canada’s healthcare industry has a growing need to produce job-ready healthcare workers. There are 1,500 open spots available in 2020-21.  WEBSITE

LSBC Membership Discounts on Job Postings

 

As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's  The Petri Dish After your first five reposts, you will also receive 25% off all job postings on  The Petri Dish . Want more info?  CONTACT: Sue Callaghan - [email protected]

Membership Benefits Program

COST SAVINGS FOR OUR MEMBERS

As a LifeSciences BC member, organizations and their employees can benefit from significant savings on a range of business and personal services, thanks to our Membership Benefits Program partnerships. You can locate the cost savings program suited to you needs here .